MYX vs NTI

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

MYX

M PHARMA FPO [MYX]

48LOW

NTI

NEUROTECH FPO [NTI]

48LOW

Score Breakdown

MYX NTI
Technical
78
51
Catalyst
87
66
Sentiment
50
50
Fundamental
87
70
Momentum
27
42
Risk Gate
45
31

Key Metrics

MYX Metric NTI
$189.7MMarket Cap$14.3M
599KAvg Volume (20d)840K
+2.9%Short InterestN/A
$7.29552-Week High$0.037
$2.04052-Week Low$0.010
+3.8%Daily Change+9.1%
$2.335Entry Price$0.012
-20.6%ROE-66.3%
-20.4%Profit Margin-54.4%

Active Signals

MYX Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Volume surging at 2.8x normal while price climbs — real buying conviction behind this move
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.5x)
●EPS estimates revised upward (+10pts)

NTI Signals

●Below the 200-day average — the long-term trend is still working against it
●Strong cash runway (9 quarters)
●Low P/S ratio (2.0x)
●Strong revenue growth (+4069%)
●Near 52-week low (4% of range)
●Micro-cap ($5-20M) - high risk
●Deeply negative margins (-54%)
●Not enough chatter to gauge sentiment — defaulting to neutral

Ask Scout AI to compare MYX and NTI in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
MYX Full Analysis → NTI Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).